info@marketresearchfuture.com   📞  +1 (855) 661-4441(US)   📞  +44 1720 412 167(UK)

Blood Test Uses AI and Biomarkers to Identify and Detect Heart Defects Before Birth

By Indu Tyagi Ketan , 25 November, 2022

A biomarker is described as a biological molecule found in blood, body fluids, or tissues that indicates the presence of a standard or abnormal process and a condition or disease. Usually, it assesses how well the body responds to an illness or condition treatment. It is also known as a molecular marker and a signature molecule.

Recently, researchers at Beaumont and Royal Oak Hospital have discovered a new blood test that analyses fetal DNA extracted from maternal blood using artificial intelligence that has the potential to aid in the early detection of heart problems and reduce infant mortality.

The researchers wanted to use a minimally invasive method to aid in early detection in this study. They hypothesized that because epigenomics and epigenetics are essential mechanisms for controlling gene expression in cardiac development, whole-genome and AI-based analysis had a high potential to detect signs of heart defects in fetal DNA found in maternal blood samples.

To put this hypothesis to the test, the researchers looked at the ability of various AI approaches, combined with genomic data, to identify altered gene pathways that are important in the development of congenital heart defects. To test the models, they used data from 12 cases of isolated non-syndromic congenital heart defects and 26 matched controls. The best-performing model accurately detected epigenetic changes and altered gene pathways related to the cardiovascular system and function development, cardiac hypertrophy, congenital heart anomaly, and cardiovascular disease. The model used five whole-genome biomarkers and had an area under the receiver operating characteristic curve of 0.97, with 98 percent sensitivity and 94 percent precision.

It was discovered that congenital disabilities, especially those caused by heart disease, are a leading cause of infant mortality. These include the most common, a hole in the heart and other potentially fatal cardiac congenital disabilities that may affect oxygen levels and blood flow at the birth, valve, and other abnormalities. Tobacco use, alcohol consumption, environmental toxins, and vitamin deficiency are all known risk factors for congenital heart defects. These agents cause chemical ('epigenetic') changes in DNA, which can affect the function of genes essential for heart development.

According to the Centers for Disease Control and Prevention (CDC), congenital disabilities affect one in every 33 infants in the US, making them the leading cause of infant mortality. Over 4,000 infants die each year due to congenital disabilities, and those who survive and live with these defects are more likely to develop lifelong cognitive, physical, and social issues.

                              Evolution of Cardiac Biomarkers 

Biomarkers.jpg

Latest News

years.png
Monetization of EV Charging Stations Helps to Promote Infrastructure Set Up Rapidly

The world is shifting towards electrification in the automotive industry. Therefore, the demand for electric charging stations is multiplying in 2024. Different nations are setting ambitious goals to adopt electrification in the transportation…

Read More

2023.png
Global Services and Businesses Slowdown due to Major Breakdown in the IT Sector

Globally, businesses and services go through a slow recovery in 2024. This is due to excessive information technology outages in computer systems across several companies. Further, it states that the recent crash with Microsoft services slowed the…

Read More

2024.png
China’s Ban on Rare Earths Export Affects Electric Vehicles Production in Western Economies

China is progressing in different industrial applications with its sky-high productivity of raw materials in 2024. China's announcement to ban rare earth elements exports significantly affects the energy sector. The nation's strong step to limit its…

Read More

Growth.png
DeepSeek vs. ChatGPT: A New Challenger Emerges in the AI Arena

The AI landscape is rapidly evolving, with new large language models (LLMs) constantly emerging and competing for dominance in a market poised for explosive growth. While the generative AI market is estimated to grow from USD 40 billion in 2024 to…

Read More

Growth.png
DeepSeek vs. ChatGPT: A New Challenger Emerges in the AI Arena one

The AI landscape is rapidly evolving, with new large language models (LLMs) constantly emerging and competing for dominance in a market poised for explosive growth. While the generative AI market is estimated to grow from USD 40 billion in 2024 to…

Read More

Author Pic
Indu Tyagi Ketan

Chief Strategy Officer